Cellular and molecular landscape of primary dermatofibrosarcoma protuberans: Insights from single-cell RNA sequencing analysis - PubMed
Cellular and molecular landscape of primary dermatofibrosarcoma protuberans: Insights from single-cell RNA sequencing analysis
Rui Peng et al. Exp Dermatol. 2024 Aug.
Abstract
Dermatofibrosarcoma protuberans (DFSP) is a rare cutaneous sarcoma characterized by the COL1A1-PDGFB fusion gene. This study utilized single-cell RNA sequencing to dissect the cellular and molecular landscape of primary DFSP. Distinct DFSP cell clusters, exhibiting fibroblast-like traits, revealed variations in pathways associated with proliferation, inflammation and metabolism. Differential gene expression analysis during the differentiation from tumour stem cells to DFSP cells unveiled SMOC2, DCN and TGFBR3 as potential regulators of tumour invasion and immune infiltration through VEGF/TGF-β signalling modulation. Cellular communication analysis highlighted interactions within DFSP cell clusters and with endothelial cells, implicating molecules such as NAMPT, ANGPT2 and PTN in pathogenesis and treatment resistance. These findings offer insights into DFSP intratumour heterogeneity, elucidate molecular mechanisms underlying tumour behaviour, and suggest potential therapeutic targets.
Keywords: dermatofibrosarcoma; single‐cell gene expression analysis; transcriptome.
© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Peng R, Zhang G, Li H. Peng R, et al. Dermatol Surg. 2023 May 1;49(5S):S27-S33. doi: 10.1097/DSS.0000000000003771. Epub 2023 Mar 30. Dermatol Surg. 2023. PMID: 37115997
-
Genomic alterations of dermatofibrosarcoma protuberans revealed by whole-genome sequencing.
Peng C, Jian X, Xie Y, Li L, Ouyang J, Tang L, Zhang X, Su J, Zhao S, Liu H, Yin M, Wu D, Wan M, Xie L, Chen X. Peng C, et al. Br J Dermatol. 2022 Jun;186(6):997-1009. doi: 10.1111/bjd.20976. Epub 2022 Apr 19. Br J Dermatol. 2022. PMID: 35441365 Free PMC article.
-
Durgin JS, Whittington CP, Joseph M, Harms PW, Andea AA, Pedersen EA, Smith EH, Harms KL. Durgin JS, et al. J Cutan Pathol. 2024 Jul;51(7):490-495. doi: 10.1111/cup.14612. Epub 2024 Mar 28. J Cutan Pathol. 2024. PMID: 38548658 Review.
-
Dermatofibrosarcoma Protuberans.
Allen A, Ahn C, Sangüeza OP. Allen A, et al. Dermatol Clin. 2019 Oct;37(4):483-488. doi: 10.1016/j.det.2019.05.006. Dermatol Clin. 2019. PMID: 31466588 Review.
References
REFERENCES
-
- Patel KU, Szabo SS, Hernandez VS, et al. Dermatofibrosarcoma protuberans COL1A1‐PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays. Hum Pathol. 2008;39(2):184‐193. doi:10.1016/j.humpath.2007.06.009
-
- Trinidad CM, Wangsiricharoen S, Prieto VG, Aung PP. Rare variants of dermatofibrosarcoma protuberans: clinical, histologic, and molecular features and diagnostic pitfalls. Dermatopathology. 2023;10(1):54‐62. doi:10.3390/dermatopathology10010008
-
- Llombart B, Monteagudo C, Sanmartín O, et al. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1‐PDGFB), and therapeutic study of low‐grade versus high‐grade (fibrosarcomatous) tumors. J Am Acad Dermatol. 2011;65(3):564‐575. doi:10.1016/j.jaad.2010.06.020
-
- Peng R, Zhang G, Li H. COL1A1‐PDGFB fusion gene detection through bulk RNA‐Seq and transcriptomic features of dermatofibrosarcoma protuberans. Dermatol Surg. 2023;49(5S):S27‐S33. doi:10.1097/DSS.0000000000003771
-
- Ge LL, Wang ZC, Wei CJ, et al. Unraveling intratumoral complexity in metastatic dermatofibrosarcoma protuberans through single‐cell RNA sequencing analysis. Cancer Immunol Immunother. 2023;72(12):4415‐4429. doi:10.1007/s00262-023-03577-2
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous